MRI scans not catching all high grade prostate tumors

Jodelle Maglaya | | Health Imaging | Cardiac Imaging

According to investigators who reported their fidings at the Society of Urologic Oncology's 17th annual meeting, standard 12-core prostate biopsies need to be given regardless if there were no findings of prostate lesions on MRI scans.

Researchers found that in their study, 13 percent of high grade prostate tumors were not seen on a prostate MRI and later revealed by transrectal ultrasound (TRUS) 12-core biopsy. 

Lead investigator Eric Kim, MD and his colleagues at Washington University School of Medicine in St. Louis studied 84 men with negative prostate MRI who then underwent standard TRUS prostate biopsy. 

See results here:

Standard TRUS Prostate Biopsy Needed Despite Negative MRIs

Jodelle Maglaya

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
FDA clears AI screening tool for cardiac amyloidosis
Global shortage of nuclear imaging isotopes may be over
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
FDA clears AI tool that flags signs of heart disease in chest CT scans
AI-enabled plaque assessments help cardiologists ID high-risk CAD patients

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.